Shukra Pharmaceuticals EGM Approves Preferential Issue of Warrants

Shukra Pharmaceuticals Ltd held its Extra Ordinary General Meeting (EOGM) on July 06, 2026, via Video Conferencing. The sole resolution presented, concerning the preferential issue of 46,43,000 Convertible Equity Warrants to Promoters for cash consideration, was passed. The meeting was conducted in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results of the e-voting process, along with the Scrutinizer's Report dated July 06, 2026, have been submitted and will be available on the company's website. The resolution received unanimous approval from the voting shareholders.